Texas Oncology Baylor Charles A. Sammons Cancer Center

Clinical research site in Dallas, Texas · Texas Oncology-Baylor Charles A. Sammons Cancer Center, 3410 Worth St STE 400, Dallas, TX 75246 · (214) 370-1000 · Website

Part of US Oncology

As of July 2026, 22 paid clinical trials are recruiting at Texas Oncology Baylor Charles A. Sammons Cancer Center in Dallas, Texas. Active studies at this site cover conditions such as Small Cell Lung Cancer and Pancreatic Neuroendocrine Tumor (pNET). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Texas Oncology Baylor Charles A. Sammons Cancer Center (22)

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for Neoplasms

77 locations incl. Birmingham

Sponsor: Celgene

Sex: All·Age: All ages

Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018

Apply to this trial

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for Small Cell Lung Cancer

27 locations incl. Daphne

Sponsor: Puma Biotechnology, Inc.

Sex: All·Age: 18+

Code: NCT06095505·Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for Pancreatic Neuroendocrine Tumor (pNET)

40 locations incl. Birmingham

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT06943755·Phase 2, Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer

37 locations incl. Birmingham

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT06901531·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for Breast Cancer

24 locations incl. Los Angeles

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT05768139·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for Breast Cancer

49 locations incl. Mobile

Sponsor: Greenwich LifeSciences, Inc.

Sex: All·Age: 18 - 100

Code: NCT05232916·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for Breast Cancer

79 locations incl. Phoenix

Sponsor: BriaCell Therapeutics Corporation

Sex: All·Age: 18+

Code: NCT06072612·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for Advanced Cancer

37 locations incl. Birmingham

Sponsor: Artios Pharma Ltd

Sex: All·Age: 18+

Code: NCT04657068·Phase 1, Phase 2·Recruiting·Listed Dec 2020

Apply to this trial

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for AML

36 locations incl. Gilbert

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT06001788·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for cGVHD

31 locations incl. Birmingham

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT05919511·Recruiting·Listed Jun 2023

Apply to this trial

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for Breast Cancer

113 locations incl. Anchorage

Sponsor: Agendia

Sex: All·Age: 18+

Code: NCT03053193·Recruiting·Listed Feb 2017

Apply to this trial

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

for Solid Tumors

15 locations incl. Bellflower

Sponsor: Mirati Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT07415031·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

for Adult Acute Myeloid Leukemia

13 locations incl. Duarte

Sponsor: Priothera SAS

Sex: All·Age: 18 - 75

Code: NCT05429632·Phase 3·Recruiting·Listed Jun 2022

Apply to this trial

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for Advanced Solid Tumor

10 locations incl. Encinitas

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06108050·Phase 1·Recruiting·Listed Oct 2023

Apply to this trial

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

for Diffuse Large B-Cell Lymphoma

7 locations incl. Tucson

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT05512390·Phase 1·Recruiting·Listed Aug 2022

Apply to this trial

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

for B-Cell Non-Hodgkin's Lymphoma (NHL)

2 locations incl. Sacramento

Sponsor: Estrella Biopharma, Inc.

Sex: All·Age: 18+

Code: NCT06343311·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

for Breast Cancer

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: All·Age: 18+

Code: NCT06517212·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

for Breast Cancer

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: Female·Age: 18+

Code: NCT04265872·EARLY_Phase 1·Recruiting·Listed Feb 2020

Apply to this trial

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for Cervical Cancer

126 locations incl. Goodyear

Sponsor: GOG Foundation

Sex: Female·Age: 18+

Code: NCT04831580·Recruiting·Listed Apr 2021

Apply to this trial

Analysis of Graft Function Following Autologous Islet Transplantation

for Chronic Pancreatitis

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: All·Age: 18+

Code: NCT03097185·Recruiting·Listed Mar 2017

Apply to this trial

Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

for Pancreatic Adenocarcinoma

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: All·Age: 18+

Code: NCT04926467·Phase 2·Recruiting·Listed Jun 2021

Apply to this trial

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

for Metastatic Triple-Negative Breast Carcinoma

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: Female·Age: 18+

Code: NCT06008275·EARLY_Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

More research sites in Dallas

University of Texas Southwestern Medical Center (189 trials)
UT Southwestern Medical Center (168 trials)
UT Southwestern/Simmons Cancer Center-Dallas (73 trials)
University of Texas Southwestern (63 trials)
Baylor University Medical Center (43 trials)
Medical City Dallas Hospital (26 trials)
The University of Texas Southwestern Medical Center (25 trials)
Parkland Memorial Hospital (24 trials)
Mary Crowley Cancer Research (23 trials)
UT Southwestern (23 trials)

Explore more

Paid clinical trials in Dallas, TX · Texas clinical trials